PT2959899T - Utilização de zileuton para o tratamento de pólipos nasais em pacientes com fibrose quística - Google Patents
Utilização de zileuton para o tratamento de pólipos nasais em pacientes com fibrose quísticaInfo
- Publication number
- PT2959899T PT2959899T PT151689726T PT15168972T PT2959899T PT 2959899 T PT2959899 T PT 2959899T PT 151689726 T PT151689726 T PT 151689726T PT 15168972 T PT15168972 T PT 15168972T PT 2959899 T PT2959899 T PT 2959899T
- Authority
- PT
- Portugal
- Prior art keywords
- zileuton
- treatment
- cystic fibrosis
- nasal polyps
- fibrosis patients
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161526440P | 2011-08-23 | 2011-08-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT2959899T true PT2959899T (pt) | 2017-05-18 |
Family
ID=46826905
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT151689726T PT2959899T (pt) | 2011-08-23 | 2012-08-23 | Utilização de zileuton para o tratamento de pólipos nasais em pacientes com fibrose quística |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20140323446A1 (pt) |
| EP (2) | EP2959899B1 (pt) |
| CA (1) | CA2844775A1 (pt) |
| DK (1) | DK2959899T3 (pt) |
| ES (2) | ES2624710T3 (pt) |
| HK (1) | HK1219652A1 (pt) |
| LT (1) | LT2959899T (pt) |
| PT (1) | PT2959899T (pt) |
| WO (1) | WO2013028880A1 (pt) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20210369669A1 (en) * | 2018-10-31 | 2021-12-02 | Systamedic Inc. | Autophagy activators and inhibitors of ferroptosis for preventing acute renal failure and neurotoxcity induced by certain antibiotics |
| CN113423435A (zh) * | 2018-12-28 | 2021-09-21 | 雷杰纳荣制药公司 | 使用花生四烯酸15-脂氧合酶(alox15)抑制剂治疗呼吸系统病症 |
| US11116778B2 (en) | 2019-01-15 | 2021-09-14 | Empirico Inc. | Prodrugs of ALOX-15 inhibitors and methods of using the same |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3536809A (en) | 1969-02-17 | 1970-10-27 | Alza Corp | Medication method |
| US3598123A (en) | 1969-04-01 | 1971-08-10 | Alza Corp | Bandage for administering drugs |
| US3845770A (en) | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
| US3916899A (en) | 1973-04-25 | 1975-11-04 | Alza Corp | Osmotic dispensing device with maximum and minimum sizes for the passageway |
| US4008719A (en) | 1976-02-02 | 1977-02-22 | Alza Corporation | Osmotic system having laminar arrangement for programming delivery of active agent |
| IE58110B1 (en) | 1984-10-30 | 1993-07-14 | Elan Corp Plc | Controlled release powder and process for its preparation |
| US4873259A (en) | 1987-06-10 | 1989-10-10 | Abbott Laboratories | Indole, benzofuran, benzothiophene containing lipoxygenase inhibiting compounds |
| US5073543A (en) | 1988-07-21 | 1991-12-17 | G. D. Searle & Co. | Controlled release formulations of trophic factors in ganglioside-lipsome vehicle |
| IT1229203B (it) | 1989-03-22 | 1991-07-25 | Bioresearch Spa | Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative. |
| US5120548A (en) | 1989-11-07 | 1992-06-09 | Merck & Co., Inc. | Swelling modulated polymeric drug delivery device |
| US5733566A (en) | 1990-05-15 | 1998-03-31 | Alkermes Controlled Therapeutics Inc. Ii | Controlled release of antiparasitic agents in animals |
| US5580578A (en) | 1992-01-27 | 1996-12-03 | Euro-Celtique, S.A. | Controlled release formulations coated with aqueous dispersions of acrylic polymers |
| US5591767A (en) | 1993-01-25 | 1997-01-07 | Pharmetrix Corporation | Liquid reservoir transdermal patch for the administration of ketorolac |
| ZA945146B (en) | 1993-07-14 | 1995-02-24 | Smithkline Beecham Corp | Novel synthesis |
| IT1270594B (it) | 1994-07-07 | 1997-05-07 | Recordati Chem Pharm | Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida |
| US6080874A (en) | 1997-09-25 | 2000-06-27 | Abbott Laboratories | Synthesis and isolation of N-(aryl or heteroaryl)-alkyl-N-hydroxyurea |
| WO2002055065A2 (en) * | 2001-01-16 | 2002-07-18 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Use of an ltb4 antagonist for the treatment and/or prevention of diseases caused by increased expression of mucin genes |
| AU2007217770B2 (en) * | 2006-02-21 | 2011-09-08 | Cornerstone Therapeutics Inc. | New crystal forms and pharmaceutical compositions of (+) -R-zileuton |
| JP2010515682A (ja) * | 2007-01-05 | 2010-05-13 | コーナーストーン セラピューティックス インコーポレイテッド | 喘息などの５−リポキシゲナーゼ活性上昇および／またはロイコトリエン活性上昇に関連する状態における使用のためのｒ−ジロートン |
-
2012
- 2012-08-23 EP EP15168972.6A patent/EP2959899B1/en active Active
- 2012-08-23 ES ES15168972.6T patent/ES2624710T3/es active Active
- 2012-08-23 ES ES12756594.3T patent/ES2544845T3/es active Active
- 2012-08-23 EP EP12756594.3A patent/EP2747762B1/en not_active Not-in-force
- 2012-08-23 US US14/240,046 patent/US20140323446A1/en not_active Abandoned
- 2012-08-23 WO PCT/US2012/052094 patent/WO2013028880A1/en active Application Filing
- 2012-08-23 DK DK15168972.6T patent/DK2959899T3/en active
- 2012-08-23 PT PT151689726T patent/PT2959899T/pt unknown
- 2012-08-23 LT LTEP15168972.6T patent/LT2959899T/lt unknown
- 2012-08-23 CA CA2844775A patent/CA2844775A1/en not_active Abandoned
-
2016
- 2016-06-30 HK HK16107642.9A patent/HK1219652A1/zh not_active IP Right Cessation
-
2017
- 2017-02-01 US US15/422,179 patent/US20170360747A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP2747762B1 (en) | 2015-07-01 |
| ES2544845T3 (es) | 2015-09-04 |
| ES2624710T3 (es) | 2017-07-17 |
| EP2959899B1 (en) | 2017-02-22 |
| DK2959899T3 (en) | 2017-05-01 |
| HK1219652A1 (zh) | 2017-04-13 |
| WO2013028880A1 (en) | 2013-02-28 |
| LT2959899T (lt) | 2017-06-12 |
| CA2844775A1 (en) | 2013-02-28 |
| US20140323446A1 (en) | 2014-10-30 |
| EP2959899A1 (en) | 2015-12-30 |
| US20170360747A1 (en) | 2017-12-21 |
| EP2747762A1 (en) | 2014-07-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB201115711D0 (en) | Phyto-cannabinoids for use in the treatment of cancer | |
| IL229474A0 (en) | Cannabinoids for use in the treatment of neuropathic pain | |
| HK1198133A1 (en) | Crizotinib for use in the treatment of cancer | |
| HK1201454A1 (en) | Therapeutic agents and uses thereof | |
| IL227738B (en) | A new compound for the treatment of cystic fibrosis | |
| PL2521562T3 (pl) | Ev576 do zastosowania w leczeniu zakażeń wirusowych dróg oddechowych | |
| PT2664326T (pt) | Terapia combinada para a fibrose quística | |
| ZA201304822B (en) | Azetidine derivatives useful for the treatment of metabolic and inflimmatory diseases | |
| IL235358B (en) | Tritocholine for use in the treatment of cystic fibrosis | |
| IL260078B (en) | Therapy used to treat Gaucher disease | |
| GB201118704D0 (en) | Cystic fibrosis treatment | |
| EP2781225A4 (en) | TREATMENT AGENT FOR INTESTINAL FIBROSIS | |
| EP2755982A4 (en) | SILICULAR HETEROCYCLIC DERIVATIVES AND METHOD FOR THEIR USE FOR THE TREATMENT OF VIRUS DISEASES | |
| EP2755981A4 (en) | HETEROCYCLIC COMPOUNDS CONTAINING SILYL AND METHODS OF USING THE SAME FOR TREATING VIRAL DISEASES | |
| HK1219652A1 (zh) | 齊留通在治療囊性纖維化病人的鼻息肉中的用途 | |
| ZA201307058B (en) | Use of polyaminoisoprenyl derrivatives in antobiotic or antisertic treatment | |
| GB2515440B (en) | Vesicular Formulations for use in the treatment of Rosacea | |
| PT2560662T (pt) | Sulodexide para a utilização no tratamento de patologias nas quais as metaloproteínases estão envolvidas | |
| EP2739287A4 (en) | CORTICOSTEROIDS FOR THE TREATMENT OF JOINT PAIN | |
| ZA201308176B (en) | Therapeutic treatment | |
| PL2734634T3 (pl) | Igf-1 do zastosowania do leczenia migreny | |
| GB201000499D0 (en) | Treatment of cystic fibrosis | |
| GB201000571D0 (en) | Treatment of cystic fibrosis | |
| AU2011902031A0 (en) | Improvements in medical treatment |